Organizing pneumonia in ALK+ non-small cell lung cancer treated with ceritinib: a case report

Organizing pneumonia in ALK+ non-small cell lung cancer treated with ceritinib: a case report

Abstract Introduction Anaplastic lymphoma kinase (ALK) inhibitors have been approved for non-small cell lung cancer (NSCLC) patients with ALK-rearrangement. Ceritinib, a clinically approved ALK inhibitor, is associated with some adverse reactions, including organizing pneumonia (OP). However, few ca...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiao Lin, Mengyao Xie, Dandan Ma, Dandan Zheng, Jingjing Liu, Jinyan Ye, Lehe Yang, Yao Lu
Format: Article
Language:English
Published: Springer 2025-07-01
Series:Discover Oncology
Subjects:
Ceritinib
ALK + 
Non-small cell lung cancer
Organizing pneumonia
Case report
Online Access:https://doi.org/10.1007/s12672-025-02904-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s12672-025-02904-6

Similar Items